Zobrazeno 1 - 10
of 1 541
pro vyhledávání: '"COPD exacerbation"'
Autor:
Yorusaliem Abrham, Siyang Zeng, Wendy Lin, Colin Lo, Alexander Beckert, Laurel Evans, Michelle Dunn, Brian Giang, Krish Thakkar, Julian Roman, Paul D. Blanc, Mehrdad Arjomandi
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Rationale Research studies typically quantify acute respiratory exacerbation episodes (AECOPD) among people with chronic obstructive pulmonary disease (COPD) based on self-report elicited by survey questionnaire. However, AECOPD quantificati
Externí odkaz:
https://doaj.org/article/2f1ec8c1870c440a9b1cd3656589d4fa
Autor:
Martinez FJ, Papi A, Welte T, Singh D, Galkin DV, Guasconi A, Pirondi S, Georges G, Imperato J, Hermans R
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 1433-1445 (2024)
Fernando J Martinez,1 Alberto Papi,2 Tobias Welte3,4 ,† Dave Singh,5 Dmitry V Galkin,6 Alessandro Guasconi,7 Stefania Pirondi,7 George Georges,7 Joseph Imperato,8 Ruben Hermans9 1Weill Cornell Medicine, New York–Presbyterian Hospital, New York, N
Externí odkaz:
https://doaj.org/article/e2ff96e0ea594d11848e624cb4d2bdb9
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract While studies have suggested increased risks of severe COVID-19 infection in chronic obstructive pulmonary disease (COPD), the persistent and delayed consequences of COVID-19 infection on patients with COPD upon recovery remain unknown. A pr
Externí odkaz:
https://doaj.org/article/29ff65c89f394d8cad569160a938e3fa
Autor:
Ana Muñoz Montiel, Pedro Ruiz-Esteban, Adolfo Doménech Del Río, Pedro Valdivielso, Miguel Ángel Sánchez Chaparro, Casilda Olveira
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Chronic obstructive pulmonary disease (COPD) has a high prevalence and a major impact on health-related quality of life (HRQL). COPD exacerbations are an important cause of morbidity and mortality, affecting cardiovascular risk, and are asso
Externí odkaz:
https://doaj.org/article/25f1a311c6b7416a83de649c8ad90abc
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 907-919 (2024)
Mengjiao Yang,1,2,* Yang Liu,1,* Yangyang Zhao,3,* Ziwei Wang,4 Jie He,5 Yali Wang,2 Tokie Anme6 1Graduate School of Comprehensive Human Science, University of Tsukuba, Tsukuba, Japan; 2Department of Cardiovascular Surgery, Affiliated Hos
Externí odkaz:
https://doaj.org/article/9db6e1efe60841cfaccde30103293672
Publikováno v:
The Egyptian Journal of Bronchology, Vol 18, Iss 1, Pp 1-17 (2024)
Abstract The mucosa of the respiratory system is an essential site for local vitamin D synthesis, degradation, and signaling. It modulates the inflammatory and immune response by saving the integrity of the mucosal barrier and killing the invading pa
Externí odkaz:
https://doaj.org/article/66c997af4f084109b96d80efd89f74c0
Publikováno v:
COPD, Vol 21, Iss 1 (2024)
AbstractBackground Type 2 diabetes is a frequent comorbidity in chronic obstructive pulmonary disease (COPD) patients, with the GOLD treatment recommendations asserting that the presence of diabetes be disregarded in the choice of treatment.Methods I
Externí odkaz:
https://doaj.org/article/9a238951bca04b54b5c397a2f67517c5
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/216113ebfd0744dd8706e46e195917c6
Publikováno v:
Respirology Case Reports, Vol 12, Iss 8, Pp n/a-n/a (2024)
Abstract Background Chronic obstructive pulmonary disease (COPD) is a common respiratory disease with acute exacerbation (AECOPD) being a common sequalae which negatively impact health status, rates of hospitalization and readmission, and disease pro
Externí odkaz:
https://doaj.org/article/51e1c45c29f34472a20e72734417636c
Autor:
Pradeesh Sivapalan, Valdemar Rømer, Tobias Wirenfeldt Klausen, Niklas Dyrby Johansen, Manan Pareek, Daniel Modin, Alexander Mathioudakis, Jørgen Vestbo, Josefin Eklöf, Alexander Jordan, John R. Hurst, Tor Biering-Sørensen, Jens-Ulrik Jensen
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
RationaleLong-acting muscarinic antagonists (LAMAs) reduce the risk of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), usually taken once daily in the morning. However, the circadian activity of autonomic regulation suggests th
Externí odkaz:
https://doaj.org/article/c51d3d562add4c2dbf3ed4d54834c322